the same years. We evaluated the effect of prenatal care on preterm birth rates after adjusting for maternal race and ethnicity. RESULTS: In 2012-2013, a total of 3,017,988 births among women with private insurance and 2,766,854 births among women with Medicaid met inclusion criteria (Figure 1 ). During these years, 19,784 women delivered at our hospital and met inclusion criteria. Women with national Medicaid were younger, more likely to be obese, of minority race and ethnicity, and have chronic medical comorbidities compared to privately insured patients. After adjustment for demographic factors, Medicaid-funded women had higher rates of both early (aOR 1.30; CI ¼ 1.12 e 1.32) and late (aOR 1.23; CI ¼ 1.22 e 1.24) preterm births, and their neonates had correspondingly higher rates of morbidities associated with prematurity than women with private insurance. Overall preterm birth rates decreased as prenatal visits increased. In a comparison plotted across categories of prenatal care attendance, women with national Medicaid were more likely to deliver preterm than women with hospital-based Medicaid (aOR 1.12 (CI 1.06 e 1.18)) ( Figure 2 ). CONCLUSION: There is disparity in pregnancy outcomes among Medicaid-funded women compared with privately insured women in the United States. Differences in preterm birth among women with Medicaid versus private insurance are due in part to the pregnancy care received. Women delivering at our hospital experienced fewer preterm deliveries than women in the national Medicaid cohort, and this difference was more pronounced as prenatal care utilization increased.
702 Racial disparities in maternal outcomes among pregnant women with major depressive disorder Emmeline L. Chuu
Oregon Health and Science University, Portland, OR OBJECTIVE: We sought to determine the differences in maternal outcomes in pregnancies among white, black, Hispanic, Asian/Pacific Islander, and Native American women with major depressive disorder (MDD). STUDY DESIGN: A retrospective cohort of 18,453 women with MDD and singleton, non-anomalous gestations was used to examine maternal outcomes, assessed according to race. Maternal outcomes included pregnancy-associated hypertension (PAH), gestational diabetes (GDM), chorioamnionitis, blood transfusion, endometritis, and postpartum hemorrhage (PPH). Multivariate regression analyses and chi-square tests were employed for statistical comparisons and a p-value of less than 0.05 was used to indicate statistical significance. RESULTS: Overall, race was associated with a statistically significant increase in the majority of investigated outcomes. Compared to white women, and after controlling for confounders, black women with MDD were more likely to experience PAH (OR 1.52; 95%CI 1.24-1.86) and develop chorioamnionitis (OR 1.67; 95%CI 1.21-2.31). Hispanic women were more likely to develop GDM (OR 1.57; 95%CI 1.41-1.76), chorioamnionitis (OR 1.45; 95%CI 1.21-1.74), and endometritis (OR, 1.59; 95%CI, 1.12-2.27), and PPH (OR 1.34; 95%CI, 1.14-1.58). Asian/Pacific Islander women were more likely to develop GDM (OR 2.36; 95%CI 1.96-2.82), chorioamnionitis (OR 2.9; 95%CI 2.23-3.77), endometritis (OR 1.9; 95%CI 1.04-3.46), PPH (OR 1.70; 95%CI 1.29-2.24), and require blood transfusions (OR 2.46; 95%CI 1.51-3.99). Women of other races, including Native American, had higher rates chorioamnionitis (OR 2.77; 95%CI 1.24-6.20). CONCLUSION: Non-white women with MDD experience higher rates of obstetric complications than white women, with specific complications and rates varying across races. These data suggest disparities may exist in management of pregnant women with MDD across different races.
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Oregon Health and Science University, Portland, OR OBJECTIVE: We sought to determine the differences in neonatal outcomes in pregnancies among white, black, Hispanic, Asian/Pacific Islander, and Native American women with major depressive disorder (MDD).
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